ALX Oncology Holdings Inc (ALXO)
1.515
+0.02
(+1.68%)
USD |
NASDAQ |
Nov 05, 16:00
1.53
+0.02
(+0.99%)
After-Hours: 19:16
ALX Oncology Holdings Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2020 | -2.15K% |
| March 31, 2020 | -832.7% |
| December 31, 2019 | -640.1% |
| Date | Value |
|---|---|
| September 30, 2019 | -242.4% |
| June 30, 2019 | -324.1% |
| March 31, 2019 | -410.7% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.15K%
Minimum
Jun 2020
-640.1%
Maximum
Dec 2019
-1.21K%
Average
-832.7%
Median
Mar 2020
Profit Margin (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 14.22% |
| Neurocrine Biosciences Inc | 20.86% |
| Eton Pharmaceuticals Inc | -33.51% |
| Verve Therapeutics Inc | -744.2% |
| Immuneering Corp | -- |